VSTM
VSTM
NASDAQ · Biotechnology

Verastem Inc

$9.38
-0.47 (-4.77%)
As of Nov 7, 2:03 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +49.8% upside
Low Target $11.84
Average Target $14.05
High Target $17.49
Current Price $9.38
Current
$9.38
Target
$14.05
$11.84 $14.05 avg $17.49
Scenario Analysis
Bear Case
$11.84
26.2%
Low target
Base Case
$14.05
+49.8%
Avg target
Bull Case
$17.49
+86.5%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$10.82
-13.3% from high
52-Week Low
$3.43
+173.5% from low
Target vs 52W High
$14.05
+29.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%